Glibenclamide/metformin

Last updated

Glibenclamide/metformin
Combination of
Glibenclamide Sulfonylurea
Metformin Biguanide
Clinical data
Trade names Glucovance
AHFS/Drugs.com Monograph
MedlinePlus a699055
License data
Pregnancy
category
Routes of
administration 		By mouth
ATC code
  • None
Legal status
Legal status
Identifiers
CAS Number
KEGG

Glibenclamide/metformin, also known as glyburide/metformin and sold under the brand name Glucovance, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes. [6] It contains glibenclamide, a sulfonylurea, and metformin, a biguanide. [7]

References

  1. 1 2 "TGA eBS - Product and Consumer Medicine Information Licence". Archived from the original on 23 March 2022. Retrieved 30 April 2022.
  2. ↑ "Search the TGA website". Archived from the original on 30 April 2022. Retrieved 30 April 2022.
  3. ↑ "Search the TGA website".[ dead link ]
  4. ↑ "Search the TGA website". Archived from the original on 30 April 2022. Retrieved 30 April 2022.
  5. ↑ "Glucovance- glyburide and metformin hydrochloride tablet, film coated". DailyMed. 23 April 2012. Archived from the original on 30 April 2022. Retrieved 30 April 2022.
  6. ↑ Lamos EM, Stein SA, Davis SN (December 2012). "Combination of glibenclamide-metformin HCl for the treatment of type 2 diabetes mellitus". Expert Opinion on Pharmacotherapy. 13 (17): 2545–54. doi:10.1517/14656566.2012.738196. PMID   23116560. S2CID   10305382.
  7. ↑ "Glyburide and metformin hydrochloride tablet". DailyMed. 10 June 2020. Archived from the original on 26 February 2021. Retrieved 11 August 2020.


This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.